|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.835 SEK | +2.45% |
|
+9.15% | -24.09% |
| 10/04 | Vaxxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 23/02 | Vaxxa AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Vaxxa AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was SEK 6.12 million compared to SEK 4.95 million a year ago. Revenue was SEK 6.42 million compared to SEK 5.04 million a year ago.
Net loss was SEK 2.65 million compared to SEK 3.01 million a year ago. Basic loss per share from continuing operations was SEK 1 compared to SEK 8 a year ago.
VAXXA AB 
